Cardiac Physiology in Transgenic Mice
Authors:
- 9 March 1998
- journal article
- other
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 82 (4) , 407-415
Abstract
—By use of gene targeting and/or transgenesis, it is now possible to make defined changes in genes whose functions underlie mammalian cardiovascular function. Because of technical and economic considerations, these experiments are largely confined to the mouse. Genetic modification of the loci responsible for aspects of cardiac development, differentiation, and function via gene targeting, as well as modulation of the cardiac protein complement using transgenesis, has begun to provide mouse models of cardiac hypertrophy, dilated cardiomyopathy, and hypertrophic cardiomyopathies. In order to use these animal models fully and explore their phenotypes at the whole organ and whole animal levels, the extension of cardiovascular physiological methodologies to the mouse is imperative. Techniques for exploring aspects of cardiovascular function are well developed for larger animal models, but their modification for the small size of the mouse heart and for the animal’s rapid cardiac cycle has proven to be a formidable challenge, requiring the combined efforts of the molecular biology, physiology, and cardiology communities. We review here the ability of present-day technology to obtain reproducible data on murine cardiac function at the whole organ and animal levels.Keywords
This publication has 15 references indexed in Scilit:
- Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice.Journal of Clinical Investigation, 1997
- Ras-dependent pathways induce obstructive hypertrophy in echo-selected transgenic miceProceedings of the National Academy of Sciences, 1997
- Rescue of cardiac α-actin-deficient mice by enteric smooth muscle γ-actinProceedings of the National Academy of Sciences, 1997
- Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy mice.Journal of Clinical Investigation, 1997
- Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart.Journal of Clinical Investigation, 1996
- Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice.Proceedings of the National Academy of Sciences, 1996
- A Mouse Model of Familial Hypertrophic CardiomyopathyScience, 1996
- Ventricular Expression of a MLC-2v-ras Fusion Gene Induces Cardiac Hypertrophy and Selective Diastolic Dysfunction in Transgenic MiceJournal of Biological Chemistry, 1995
- Gene targeting in the mouseBioEssays, 1994
- Enhanced Myocardial Function in Transgenic Mice Overexpressing the β 2 -Adrenergic ReceptorScience, 1994